Summary:
Reliance Life Sciences is developing a wide range of novel research-led, cell-based therapies with the objective of bringing about an era of regenerative medicine. Several groups work in the areas of Embryonic Stem Cells and Stem Cell Enriched Cord Blood Repository.
Visit Reliance Life Sciences.

Description (Web site quote):
Reliance Life Sciences is a new millennium initiative of the Reliance Group. Reliance Life Sciences was incorporated in the year 2001. Reliance Group is the largest private sector enterprise in India, participating in businesses in the energy and materials value chain, with group revenues of USD 24 billion. The flagship company, Reliance Industries Limited, is a Fortune Global 500 company. Reliance Life Sciences is developing business opportunities in the domains of medical biotechnology, plant biotechnology, industrial biotechnology, clinical research services and contract manufacturing. From a domain perspective, these opportunities cover biopharmaceuticals, molecular diagnostics and genetics, cell-based therapies, plant tissue culture, plant metabolic engineering, biofuels, biopolymers, biochemicals, clinical research services and contract manufacturing. From an integration perspective, these opportunities encompass repositories, research, process development, pre-clinical studies, human clinical trials, manufacture and marketing, all of which are carried out in-house. We believe that the Reliance Life Sciences initiative is one of the most diverse and integrated biotechnology initiatives being developed anywhere in the world. We have a professional team comprising substantially of Ph.Ds, M.Ds, Engineers and Post Graduates in Science. The average age of the Reliance Life Sciences team is 31 years. One-third of our employees are women.
Visit Reliance Life Sciences.